[1] |
Kim TH, Sung HH, Jeon HG, et al.Oncological outcomes in patients treated with radical cystectomy for bladder cancer: comparison between open, laparoscopic, and robot-assisted approaches[J].J Endourol, 2016, 30(7): 783-791.DOI: 10.1089/end.2015.0652.
|
[2] |
Khan MS, Omar K, Ahmed K, et al.Long-term oncological outcomes from an early phase randomised controlled three-arm trial of open,robotic, and laparoscopic radical cystectomy (CORAL)[J].Eur Urol,2020, 77(1): 110-118.DOI: 10.1016/j.eururo.2019.10.027.
|
[3] |
胡影,常莹莹,吴彤.机器人辅助根治性膀胱切除术对男性患者性功能、控尿功能和生存质量的影响[J].中华男科学杂志, 2024,30(4): 378-380.DOI: 10.13263/j.cnki.nja.2024.04.014.Hu Y, Chang YY, Wu T.Impact of robot - assisted radical cystectomy on sexual function, urinary continence and quality of life in male patients [J].Chin J Androl, 2024, 30 (4): 378-380.DOI: 10.13263/j.cnki.nja.2024.04.014.
|
[4] |
周高峰, 郑志平, 朱锦智, 等.腹膜外入路腹腔镜下根治性膀胱切除术临床效果评估及应用价值[J].中华肿瘤防治杂志, 2023,30(19): 1177-1183.DOI: 10.16073/j.cnki.cjcpt.2023.19.06.Zhou GF, Zheng ZP, Zhu JZ, et al.Evaluation of clinic outcomes and application value of extraperitoneal laparoscopic radical cystectomy[J].Chin J Cancer Prev Treat, 2023, 30(19): 1177-1183.DOI: 10.16073/j.cnki.cjcpt.2023.19.06.
|
[5] |
de Jong JJ, Lotan Y, Boormans JL.Re: EAU guidelines on muscleinvasive and metastatic bladder cancer[J].Eur Urol, 2024, 86(5):480-481.DOI: 10.1016/j.eururo.2024.07.023.
|
[6] |
Iwata T, Kimura S, Abufaraj M, et al.The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review[J].Urol Oncol, 2019, 37(10): 659-671.DOI: 10.1016/j.urolonc.2019.05.021.
|
[7] |
Zaghloul MS, Christodouleas JP, Smith A, et al.Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial[J].JAMA Surg, 2018, 153(1): e174591.DOI: 10.1001/jamasurg.2017.4591.
|
[8] |
Zaghloul MS, Alnagmy AK, Kasem HA, et al.The value and safety of adjuvant radiation therapy after radical cystectomy in locally advanced urothelial bladder cancer: a controlled randomized study[J].Int J Radiat Oncol Biol Phys, 2024, 120(3): 658-666.DOI: 10.1016/j.ijrobp.2024.05.012.
|
[9] |
Kim HJ, Chun J, Kim TH, et al.Patterns of locoregional recurrence after radical cystectomy for stage T3-4 bladder cancer: a radiation oncologist's point of view[J].Yonsei Med J, 2021, 62(7): 569-576.DOI: 10.3349/ymj.2021.62.7.569.
|
[10] |
Huguet J.Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors[J].Actas Urol Esp, 2013,37(6): 376-382.DOI: 10.1016/j.acuro.2013.01.005.
|
[11] |
Sargos P, Baumann BC, Eapen L, et al.Risk factors for locoregional recurrence after radical cystectomy of muscle-invasive bladder cancer: a systematic-review and framework for adjuvant radiotherapy[J].Cancer Treat Rev, 2018, 70: 88-97.DOI: 10.1016/j.ctrv.2018.07.011.
|
[12] |
Kar A, Satapathy B, Pattnaik K, et al.Trucut biopsy vs FNAC of pelvic tumors-who wins the match?[J].J Cytol, 2018, 35(3): 179-182.DOI: 10.4103/JOC.JOC_63_18.
|
[13] |
Gupta S, Nguyen HL, Morello FA Jr, et al.Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations[J].Radiographics, 2004, 24(1): 175-189.DOI: 10.1148/rg.241035063.
|
[14] |
Zikan M, Fischerova D, Pinkavova I, et al.Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology[J].Ultrasound Obstet Gynecol, 2010, 36(6): 767-772.DOI: 10.1002/uog.8803.
|
[15] |
Picozzi S, Ricci C, Gaeta M, et al.Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13, 185 patients[J].J Urol, 2012, 188(6): 2046-2054.DOI: 10.1016/j.juro.2012.08.017.
|
[16] |
Fernández MI, Parikh S, Barton Grossman H, et al.The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer[J].Urol Oncol, 2012, 30(6): 821-824.DOI: 10.1016/j.urolonc.2010.08.006.
|
[17] |
Chen X, Zhang J, Ruan W, et al.Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer[J].J Clin Invest, 2020, 130(12): 6278-6289.DOI: 10.1172/JCI139597.
|
[18] |
Rodríguez-Serrano A, Carrión DM, Rivas JG, et al.Prognostic value of urinary cytology for detecting urothelial carcinoma recurrence after radical cystectomy[J].Actas Urol Esp (Engl Ed), 2021, 45(6):466-472.DOI: 10.1016/j.acuroe.2021.06.001.
|
[19] |
Ballas L, Wei O, Daneshmand S, et al.Chemoradiation for management of locally recurrent or residual bladder cancer: a case series and review of the literature[J].Clin Genitourin Cancer, 2020,18(4): e473-e477.DOI: 10.1016/j.clgc.2019.12.016.
|
[20] |
Vilaseca A, Huguet J, Pérez M, et al.The role of surgery in local recurrences after radical cystectomy for bladder cancer[J].Urol Int,2016, 96(2): 132-135.DOI: 10.1159/000443336.
|
[21] |
Liu MA, Li JW, Runcie K.Management of oligometastatic and locally recurrent urothelial carcinoma[J].Curr Oncol Rep, 2024,26(5): 496-503.DOI: 10.1007/s11912-024-01523-8.
|
[22] |
高佳宁, 李浩, 刘静雅, 等.不同预防性膀胱内化疗方案对上尿路尿路上皮癌肾输尿管切除术后膀胱癌复发的影响[J].现代肿瘤医学, 2023, 31(4): 712-718.DOI:10.3969/j.issn.1672-4992.2023.04.023.Gao JN, LiH, Liu JY, et al.Effects of different prophylactic intravesical chemotherapy regimens on bladder cancer recurrence after nephroureterectomy in patients with upper tract urothelial carcinoma [J].Chin J Mod Oncol, 2023, 31(4): 712-718.DOI:10.3969/j.issn.1672 - 4992.2023.04.023.
|
[23] |
Dobruch J, Oszczudłowski M.Bladder cancer: current challenges and future directions[J].Medicina (Kaunas), 2021, 57(8): 749.DOI:10.3390/medicina57080749.
|
[24] |
Compérat E, Amin MB, Cathomas R, et al.Current best practice for bladder cancer: a narrative review of diagnostics and treatments[J].Lancet, 2022, 400(10364): 1712-1721.DOI: 10.1016/S0140-6736(22)01188-6.
|